The Lesion of the Rat Substantia Nigra pars compacta Dopaminergic Neurons as a Model for Parkinson's Disease Memory Disabilities

被引:0
|
作者
Claudio Da Cunha
Miriam Elizabeth Mendes Angelucci
Newton S. Canteras
Susan Wonnacott
Reinaldo N. Takahashi
机构
[1] Laboratório de Fisiologia e Farmacologia do SNC,Departamento de Farmacologia, UFPR
[2] University of Bath,Department of Biology and Biochemistry
[3] UFSC,Departamento de Farmacologia
来源
关键词
Parkinson's disease; MPTP; substantia nigra pars compacta; memory; striatum; dopamine; caffeine;
D O I
暂无
中图分类号
学科分类号
摘要
1. In this article we review the studies of memory disabilities in a rat model o Parkinson's disease (PD).
引用
收藏
页码:227 / 237
页数:10
相关论文
共 50 条
  • [31] Neuropeptide apelin presented in the dopaminergic neurons modulates the neuronal excitability in the substantia nigra pars compacta
    Liu, Cui
    Kang, Nan-Wei
    Wang, Ying
    Xue, Yan
    Chen, Xin-Yi
    Chen, Lei
    NEUROPHARMACOLOGY, 2022, 219
  • [32] Neuropeptide apelin presented in the dopaminergic neurons modulates the neuronal excitability in the substantia nigra pars compacta
    Liu, Cui
    Kang, Nan-Wei
    Wang, Ying
    Xue, Yan
    Chen, Xin-Yi
    Chen, Lei
    NEUROPHARMACOLOGY, 2022, 219
  • [33] Synuclein Proteins in MPTP-Induced Death of Substantia Nigra Pars Compacta Dopaminergic Neurons
    Goloborshcheva, Valeria V.
    Kucheryanu, Valerian G.
    Voronina, Natalia A.
    Teterina, Ekaterina V.
    Ustyugov, Aleksey A.
    Morozov, Sergei G.
    BIOMEDICINES, 2022, 10 (09)
  • [34] Age and Parkinson's Disease-Related Neuronal Death in the Substantia Nigra Pars Compacta
    Eriksen, Nina
    Stark, Anette Kirstine
    Pakkenberg, Bente
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 2009, (73): : 203 - 213
  • [35] Testing efficacy of the nicotine protection of the substantia nigra pars compacta in a rat Parkinson disease model. Ultrastructure study
    Elgayar, S. A. M.
    Hussein, Ola A.
    Mubarak, Heba A.
    Ismaiel, Amany M.
    Gomaa, Asmaa M. S.
    ULTRASTRUCTURAL PATHOLOGY, 2022, 46 (01) : 37 - 53
  • [36] Regulation of c-Ret, GFRα1, and GFRα2 in the substantia nigra Pars compacta in a rat model of Parkinson's disease
    Marco, S
    Saura, J
    Pérez-Navarro, E
    Martí, MJ
    Tolosa, E
    Alberch, J
    JOURNAL OF NEUROBIOLOGY, 2002, 52 (04): : 343 - 351
  • [37] Immunohistochemical evidence for localization of NMDAR1 receptor subunit on dopaminergic neurons of the rat substantia nigra, pars compacta
    Wedzony, K
    Czepiel, K
    Fijal, K
    POLISH JOURNAL OF PHARMACOLOGY, 2001, 53 (06): : 675 - 679
  • [38] MODULATION OF FIRING ACTIVITY BY ATP IN DOPAMINE NEURONS OF THE RAT SUBSTANTIA NIGRA PARS COMPACTA
    Choi, Y. M.
    Jang, J. Y.
    Jang, M.
    Kim, S. H.
    Kang, Y. K.
    Cho, H.
    Chung, S.
    Park, M. K.
    NEUROSCIENCE, 2009, 160 (03) : 587 - 595
  • [39] INHIBITION OF PARS COMPACTA NEURONS BY DOPAMINE IN SLICES OF RAT SUBSTANTIA NIGRA MAINTAINED INVITRO
    PINNOCK, RD
    JOURNAL OF PHYSIOLOGY-LONDON, 1983, 334 (JAN): : P88 - P89
  • [40] The neuroprotective action of lenalidomide on rotenone model of Parkinson's Disease: Neurotrophic and supportive actions in the substantia nigra pars compacta
    Cankara, Fatma Nihan
    Gunaydin, Caner
    Bilge, Suleyman Sirri
    Ozmen, Ozlem
    Kortholt, Arjan
    NEUROSCIENCE LETTERS, 2020, 738